Structural basis of kynurenine 3-monooxygenase inhibition

Inhibition of kynurenine 3-monooxygenase (KMO), an enzyme in the eukaryotic tryptophan catabolic pathway (i.e. kynurenine pathway), leads to amelioration of Huntington’s disease-relevant phenotypes in yeast, fruit fly, and mouse models(1–5), as well as a mouse model of Alzheimer’s disease(3). KMO is...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Amaral, Marta, Levy, Colin, Heyes, Derren J., Lafite, Pierre, Outeiro, Tiago F., Giorgini, Flaviano, Leys, David, Scrutton, Nigel S.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736096/
https://ncbi.nlm.nih.gov/pubmed/23575632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature12039
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki